The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label trial of talimogene laherparepvec (T-VEC) plus pembrolizumab vs pembrolizumab monotherapy in previously untreated, unresected, stage IIIB-IV melanoma.
 
Antoni Ribas
Stock and Other Ownership Interests - Compugen; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Merck Sharp & Dohme (Inst)
 
Igor Puzanov
No Relationships to Disclose
 
Thomas Gajewski
Consulting or Advisory Role - Jounce Therapeutics; Merck; Ono Pharmaceutical; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Incyte; Merck; Ono Pharmaceutical; Roche/Genentech
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
John M. Kirkwood
No Relationships to Disclose
 
Ari VanderWalde
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Amgen; Roche/Genentech
 
Jonathan S. Cebon
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst)
Research Funding - CSL Behring (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Grant A. McArthur
Research Funding - Celgene; Novartis; Pfizer; Ventana Medical Systems
 
Christine K. Gause
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Lisa Chen
Employment - Amgen
 
David Ross Kaufman
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Merck
Travel, Accommodations, Expenses - Merck
 
Jeffrey Chou
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Robert Hans Ingemar Andtbacka
Consulting or Advisory Role - Amgen
Research Funding - Amgen
 
F. Stephen Hodi
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche